Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort

被引:170
作者
Newschaffer, CJ
Otani, K
McDonald, MK
Penberthy, LT
机构
[1] Johns Hopkins Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[2] St Louis Univ, Sch Publ Hlth, Dept Community Hlth, St Louis, MO 63103 USA
[3] Virginia Commonwealth Univ, Med Coll Virginia, Dept Med, Div Qual Hlth Care, Richmond, VA 23298 USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2000年 / 92卷 / 08期
关键词
D O I
10.1093/jnci/92.8.613
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Prostate cancer tends to affect older men and to progress relatively slowly, Since the prevalence of comorbidity increases with advancing age, competing causes of death are important contributors to death rates among prostate cancer patients. Accurate determination of the underlying causes of death in older men dying with prostate cancer may thus also be more difficult. Methods: We compared the distribution of underlying causes of death in decedents from a population-based cohort of elderly prostate cancer patients to that from a population-based comparison cohort of elderly men without prostate cancer. Among decedents from the prostate cancer patient cohort, we examined associations of patient demographics, disease stage, and initial treatment, with assignment of a prostate cancer underlying cause of death (versus any other cause) by use of multivariable logistic regression, In the subgroup of prostate cancer patient decedents having underlying causes of death other than prostate cancer, the underlying cause distribution was compared with that in nonprostate cancer cohort decedents, Results: Prostate cancer was the underlying cause for 39% (95% confidence interval [CI] = 36.3-41.9) of the decedents in the prostate cancer cohort, Causes of death among prostate cancer patients not dying of prostate cancer were similar to those among the nonprostate cancer cohort decedents, However, in those who were aggressively treated, the adjusted odds of other cancer causes of death were 51% higher (odds ratio [OR] = 1.51; 95% CI = 1.08-2.10) than that in nonprostate cancer patient decedents, while in those treated with watchful waiting the adjusted odds were 34% lower (OR = 0.66; 95% CI = 0.47-0.93). Conclusions: Initial treatment may influence the underlying cause of death reported in vital statistics for prostate cancer patients.
引用
收藏
页码:613 / 621
页数:9
相关论文
共 34 条
[1]   The impact of co-morbidity on life expectancy among men with localized prostate cancer [J].
Albertsen, PC ;
Fryback, DG ;
Storer, BE ;
Kolon, TF ;
Fine, J .
JOURNAL OF UROLOGY, 1996, 156 (01) :127-132
[2]  
*AM CANC SOC, 1998, CANC FACTS FIG
[3]  
Anderson R, 1995, MONTHLY VITAL STA S2, V45
[4]  
[Anonymous], SEER CANC STAT REV 1
[5]  
ARMITAGE P, 1988, STAT METHODS MED RES
[6]   NATURAL-HISTORY OF BENIGN PROSTATIC HYPERPLASIA AND RISK OF PROSTATECTOMY - THE BALTIMORE LONGITUDINAL-STUDY OF AGING [J].
ARRIGHI, HM ;
METTER, EJ ;
GUESS, HA ;
FOZZARD, JL .
UROLOGY, 1991, 38 (01) :4-8
[7]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[8]  
CHU KC, 1990, PUBLIC HEALTH REP, V105, P36
[9]   Factors that determine the treatment for local and regional prostate cancer [J].
Desch, CE ;
Penberthy, L ;
Newschaffer, CJ ;
Hillner, BE ;
Whittemore, M ;
McClish, D ;
Smith, TJ ;
Retchin, SM .
MEDICAL CARE, 1996, 34 (02) :152-162
[10]   ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619